Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia (original) (raw)
Jari Tiihonen
2019, JAMA Psychiatry
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients
Eva Peñas Lledó
European Journal of Clinical Pharmacology, 2007
View PDFchevron_right
Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic
Dr. Hülya Ensari
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014
View PDFchevron_right
Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
Nasser Al Zain
Neuropsychiatric Disease and Treatment, 2015
View PDFchevron_right
Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics
Takefumi Suzuki
Journal of Clinical Psychopharmacology, 2018
View PDFchevron_right
Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia
S. Kleisas
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
View PDFchevron_right
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data
Anatoly Kreinin
View PDFchevron_right
Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients
Isabell Heuser
Schizophrenia Research, 2010
View PDFchevron_right
Duration of Hospitalization According to the Type of Treatment in Patients Diagnosed With Schizophrenia: A Retrospective Cross-sectional Study
MohammadHosein Sheybani-Arani
Disease and diagnosis, 2023
View PDFchevron_right
Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study
Richard Laugharne
Acta Psychiatrica Scandinavica, 2006
View PDFchevron_right
ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
Jason Noel
American Journal of Health-system Pharmacy, 2020
View PDFchevron_right
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Antipsychotic management in primary care: a longitudinal population-based study
Sally Sheard
medRxiv (Cold Spring Harbor Laboratory), 2024
View PDFchevron_right
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response
Isabell Heuser
Psychiatry Research, 2008
View PDFchevron_right
Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations
Steven Batki
Journal of Psychiatric Practice, 2005
View PDFchevron_right
Review of psychotherapeutic interventions for people with schizophrenia
Lluís Lalucat i Jo
View PDFchevron_right
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
Eckart Ruether
Journal of Psychiatric Research, 2011
View PDFchevron_right
Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness
Gretchen Haas
Journal of Psychiatric Research, 1998
View PDFchevron_right
Adverse Drug Reactions Affiliated with Atypical Antipsychotics in Patients with Schizophrenia
shweta oommen
Journal of Young Pharmacists, 2019
View PDFchevron_right
Common Use of Antipsychotic Polypharmacy in Older Asian Patients With Schizophrenia (2001–2009)
Chay hoon Tan
Journal of Clinical Psychopharmacology, 2012
View PDFchevron_right
Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
Noosha Niv
CNS Drugs, 2008
View PDFchevron_right
Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia
Alison Markwick
Schizophrenia Bulletin, 2005
View PDFchevron_right
Antipsychotic Medication for Early-Episode Schizophrenia
John Bola
Schizophrenia Bulletin, 2011
View PDFchevron_right
Integrated Psychological Therapy and Treatment-Resistant Schizophrenia: Initial Findings
Stavroula Rakitzi
Psychiatry, 2019
View PDFchevron_right
The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis
Luke Vano
Molecular Psychiatry, 2019
View PDFchevron_right
Effectiveness of clozapine in treatment-resistant schizophrenia
Raguraman Janakiraman
Indian Journal of Psychiatry, 2005
View PDFchevron_right
Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy
Stephen Olson
American Journal of Psychiatry, 2011
View PDFchevron_right
S35-01 - Clinical influencing factors of acute treatment outcome in first-episode schizophrenia patients
Isabell Heuser
European Psychiatry, 2010
View PDFchevron_right
Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India
Raakhi Tripathi
Cureus
View PDFchevron_right
Pharmaceutical care in a long-stay psychiatric hospital
Ivana Ilickovic
European Journal of Hospital Pharmacy, 2015
View PDFchevron_right
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia Editorial Supplemental content
Mely Cabrera
View PDFchevron_right
Attitudes Toward Antipsychotic Medication
David Healy
Archives of General Psychiatry, 2005
View PDFchevron_right
Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia
Glenn Phillips
Psychiatry Research, 2012
View PDFchevron_right
Real World" Atypical Antipsychotic Prescribing Practices in Public Child and Adolescent Inpatient Settings
Peter Jensen
Schizophrenia Bulletin, 2002
View PDFchevron_right
Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
Diego Novick
Value in Health, 2009
View PDFchevron_right
The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
Fabian Lungu
Brain sciences, 2024
View PDFchevron_right
Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting
SELÇUK KIRLI
Human Psychopharmacology: Clinical and Experimental, 2007
View PDFchevron_right
PsychiatryMedicinePolypharmacyAntipsychoticwos